ArticleEuropean radiology2025
Contrast-enhanced CT-based prediction models for early intervention efficacy and in-hospital mortality risk in acute necrotizing pancreatitis with persistent organ failure.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical-radiological comparative evaluation of the BISAP and Computed tomography severity index scores as predictors of severity in acute pancreatitis.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo develop contrast-enhanced CT-based nomograms for predicting early intervention efficacy and in-hospital mortality in acute necrotizing pancreatitis (ANP) with persistent organ failure (POF). MATERIALS AND
methodsThis retrospective study analyzed 164 ANP patients with POF (110 in the training cohort, 54 in the validation cohort). The Sequential Organ Failure Assessment (SOFA) score was used to evaluate organ dysfunction severity. Contrast-enhanced CT parameters included mean and range CT numbers (HU) of acute necrotic collections (ANC) across anatomical regions, as well as pancreatic necrosis volume (PNV). LASSO regression identified predictors for early intervention efficacy and mortality. Nomograms were assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.
resultsEarly intervention efficacy predictors included intra-abdominal pressure, cardiovascular hemodynamic changes, and PNV increase. The model demonstrated good predictive performance, with an area under the ROC curve (AUC) of 0.848 (95% CI: 0.769-0.927) in the training cohort and 0.796 (95% CI: 0.644-0.947) in the validation cohort. In-hospital mortality predictors were SOFA score, cardiovascular hemodynamic changes, mean CT number of ANC at the right anterior pararenal space, and CT number range at the left paracolic gutter. The model showed AUCs of 0.918 (training cohort, 95% CI: 0.864-0.971) and 0.860 (validation cohort, 95% CI: 0.801-0.919).
conclusionANP patients with intra-abdominal hypertension or significant PNV increase who maintain cardiovascular hemodynamic stability are more likely to benefit from early intervention. An elevated SOFA score, persistent cardiovascular failure, and ANC with poor homogeneity or drainage difficulty are risk factors for in-hospital mortality. KEY POINTS: Question The optimal timing for early invasive intervention remains controversial in ANP with POF. Findings Nomogram models integrating organ dysfunction severity and contrast-enhanced CT imaging features can predict treatment response and clinical outcomes in ANP patients with POF. Clinical relevance Our prediction models can identify patients who may benefit from early invasive intervention and assess in-hospital mortality risk for the entire cohort, providing a practical tool to guide clinical decision-making.
Indexed as
Identifiers
40531319What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.